SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Predictors For Sickle-cell-anemia Complications, University of Texas Southwestern Medical Center Study
March 3, 2008
 · 
1 min read
Lone Star Bio
Nanomedicine System Engineered to Enhance Therapeutic Effects of Injectable Drugs
March 3, 2008
 · 
1 min read
Lone Star Bio
Arsenic Aids Tumor Imaging When Joined To Cancer-Homing Drug, University of Texas Southwestern Medical Center Researchers Find
March 3, 2008
 · 
1 min read
Lone Star Bio
M. D. Anderson Cancer Center Researchers Identify And Shut Down Protein That Fuels Ovarian Cancer
February 27, 2008
 · 
1 min read
Lone Star Bio
Cancer Research: Biochemists Solve Structure Of TGF-beta And Its Receptor, University of Texas Health Science Center Study
February 27, 2008
 · 
1 min read
Lone Star Bio
Prenatal Exposure To Lead Linked To Obesity In Males
February 22, 2008
 · 
1 min read
Lone Star Bio
Oral Contraceptives Could Work For Dogs, Cats, Pigs, Maybe Even Deer And Coyotes
February 20, 2008
 · 
1 min read
Lone Star Bio
Mesothelin Engineered On Virus-like Particles Provides Treatment Clues For Pancreatic Cancer, Baylor College of Medicine Study
February 19, 2008
 · 
1 min read
Lone Star Bio
Oncoproteins Double-team And Destroy Vital Tumor-suppressor
February 19, 2008
 · 
1 min read
Lone Star Bio
Plastic Surgeons Deploy New Carbon Dioxide-based Fractional Laser
February 18, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Moleculin Launches CEO Corner Platform to Share Strategic Insights
February 13, 2026
 · 
4 min read
Press Releases
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
February 13, 2026
 · 
11 min read
Press Releases
Medicenna Announces Changes to Board Composition
February 13, 2026
 · 
6 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
February 12, 2026
 · 
1 min read
Press Releases
Tvardi Therapeutics to Participate in Upcoming Investor Conferences - February 12, 2026
February 12, 2026
 · 
1 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
February 11, 2026
 · 
4 min read
Press Releases
IntraBio Reports Further Detail on Positive Data from Levacetylleucine Pivotal Trial for the Treatment of Ataxia-Telangiectasia
February 11, 2026
 · 
4 min read
Press Releases
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
February 11, 2026
 · 
5 min read
Press Releases
Vesalio Expands International Neurovascular Portfolio with CE Mark of NeVa VS and NeVa 3.0 mm and Receives Additional FDA 510(k) Clearance for its Aspiration Catheters
February 10, 2026
 · 
4 min read
Load More